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Abstract
 .We investigated the effect of transforming growth factor-b1 TGF-b1 on the expression of calponin-h1, a-smooth
 .  .muscle actin a-SMA , and extracellular matrix ECM components in a cultured human Ito cell line, LI90. The TGF-b 1
treatment stimulated productions of hyaluronic acid and laminin, and significantly decreased the secretion of hepatocyte
growth factor in LI90 cells. The functional characteristics of LI90 cells were compatible with those of human-activated Ito
cells that are known as pericyte-like mesenchymal liver cells. TGF-b1 induced a slight growth-inhibition of LI90 cells.
TGF-b1 enhanced the expressions of both a-SMA and calponin-h1 at the protein level, while tumor necrosis factor-a and
interleukin-1a did not affect the expressions of these cytoskeletal proteins on LI90 cells. The addition of TGF-b1 to LI90
cells resulted in a significant increase of calponin-h1 mRNA levels, but not calponin-h2. These data suggest that the
expression of calponin-h1 is controlled at the level of mRNA under the coordinate regulation together with a-SMA as the
process of perpetuation of activated Ito cells promoted by TGF-b1. The identification of smooth muscle features promoted
by TGF-b1 support the hypothesis that the activation of Ito cells coincides with their contractile behavior, indicating that
these cells may be important in vasoregulation during liver injury and fibrosis. q 1998 Elsevier Science B.V. All rights
reserved.
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1. Introduction
Advances in the isolation and characterization of
liver cells, in conjunction with progress in matrix and
cytokine biology, have led to important insights about
w xthe cellular basis of hepatic fibrosis 1 . In the normal
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liver, Ito cells also known as fat-storing cells,
.lipocytes, or stellate cells that thought to be analo-
gous to tissue pericytes are located in the perisinu-
soidal space and characterized by lipid droplets con-
w xtaining vitamin A 2 . In particular, Ito cells have
now been clearly identified as the primary cellular
 .source of extracelluar matrix ECM components in
w xhepatic fibrosis 3 . In the process of hepatic fibrosis,
Ito cells lose their vitamin A store and there is an
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increase in the amount of rough endoplasmic reticu-
w xlum and thin-filament bundles 4 . In morphological
studies, this phenotypic modulation is referred to as
the ‘activation’ of Ito cells. Such activated Ito cells
exhibit some of the morphologic features of myofi-
broblasts, which express an intermediate phenotype
between that of fibroblasts and smooth muscle cells,
to produce ECM proteins such as collagen type I, III
w xand IV, fibronectin, and laminin 5 . It is well ac-
cepted that human-activated Ito cells contain a-
 .smooth muscle actin a-SMA as the major protein
of thin filaments, and that their appearance is associ-
ated with the process of hepatic fibrosis and the
w xformation of liver nodules in humans 6 . The process
of activation in Ito cells is a cascade occurring in at
w xleast two steps 1,7 . The initiation is characterized by
the expression of a-SMA and the induction of cy-
tokine receptors. The perpetuation reflects the subse-
quent effects of proliferative and fibrogenic cytokines
on the cells.
Calponin has been isolated as an actin-associated
w xprotein from several smooth muscle tissues 8 .
Calponin is also an tropomyosin- and calmodulin-bi-
nding protein that is implicated in the auxiliary role
w xof smooth muscle contraction 9 . The association of
calponin with the actin filament results in the inhibi-
tion of actin-activated myosin MgATPase activity
w x10 . cDNAs encoding two smooth muscle calponins,
designated h1 and h2, and an acidic calponin, which
is a non-muscle isoform with distinct functional prop-
w xerties, have been isolated 9,11–13 . The cDNA
cloning and sequence data suggest that the h1-, h2-
and acidic calponins are encoded by different genes.
Interestingly, only the calponin-h1 protein is de-
tectable in smooth muscle tissues, and it is down-reg-
ulated rapidly during smooth muscle cell culture
w x11,14 .
 .Transforming growth factor-b TGF-b consists
of a family of polypeptides with multiple functions in
growth and differentiation, depending on the cell type
w xand cell environment 15 . To date, three mammalian
isoforms have been identified: TGF-b1, -b 2, and
w x
-b 3 15 . This family of regulatory factors has been
demonstrated to be important in embryonic morpho-
genesis, wound healing and inflammatory processes
w x15 . TGF-b is also a potent stimulator of ECM
formation, and its enhanced action can lead to the
development of fibrosis in many tissues and organs.
A recent study demonstrated that TGF-b1 has stimu-
latory effects on the synthesis of ECM by cultured Ito
w xcells 16 . In addition, TGF-b1 promoted a pheno-
typic transition of quiescent Ito cells in the rat liver
into myofibroblast-like cells characterized by a high
w xlevel of a-SMA expression 16 . However, a-SMA
is expressed in the cardiac, skeletal and smooth mus-
cle cell lineages during embryogenesis and in the
adult, suggesting that its existence is not always a
valuable marker for the specific lineage of smooth
w xmuscle cells 17 . Most in vitro studies of Ito cells
have been performed in rat liver-derived cells. Re-
garding the process of activation in Ito cells derived
from the human liver, little information is available
concerning the cytoskeletal components in the acto-
myosin-linked system, except for intermediate fila-
ments. This led us to investigate the expression of
calponin-h1, especially in human Ito cells, since its
expression is highly specific for smooth muscle cells.
w xMurakami et al. 18 recently established a new cell
line, LI90, that exhibited morphologic and functional
characteristics compatible with those of Ito cells. To
identify the factors regulating the expression of
smooth muscle-specific proteins, we investigated the
effect of TGF-b on the expression of a-SMA and
calponin-h1 in LI90 cells.
2. Materials and methods
2.1. Cell culture
LI90 cells that exhibited characteristics compatible
with those of Ito cells from a human hepatic mes-
enchymal tumor were kindly provided by Dr. K.
 . w xMurakami Tohoku University, Sendai, Japan 18 .
The cells were cultured in Dulbecco’s modified Ea-
gle’s medium DMEM; Gibco Laboratories, Grand
.Island, NY, USA supplemented with 10% fetal calf
 .serum FCS; Gibco , 100 Urml penicillin and 100
 .mgrml streptomycin both Gibco . Cultures were
incubated at 378C in a humidified atmosphere of 5%
CO2r95% air with medium changes twice a week.
For proliferation assays, LI90 cells were cultured in
 .6-well plates Costar, Cambridge, MA, USA at 4=
104 cellsrwell in 10% FCS in the absence or pres-
ence of TGF-b1 for 96 h.
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2.2. Measurement of hyaluronic acid, laminin, and
hepatocyte growth factor
LI90 cells were cultured to confluence in DMEM.
They were washed twice and incubated in fresh
medium with or without the addition of TGF-b1 for
48 h. The conditioned medium was collected and
clarified by centrifugation at 12,000 g for 5 min.
 .Hyaluronic acid HA was measured by a sandwich
enzyme-binding assay Chugai Pharmaceuticals,
.Tokyo, Japan using HA-binding protein as the solid
phase and biotin-conjugated HA-binding protein as
w xthe liquid phase 19 . The laminin level was deter-
mined with the use of an enzyme-immunoassay kit
 .Fuji Chemicals, Toyama, Japan and a pair of mono-
clonal antibodies against human laminin P1 fragment
w x  .20 . Hepatocyte growth factor HGF was assessed
by means of a previously reported enzyme-im-
munoassay Otsuka Assay Laboratories, Tokushima,
. w xJapan 21 . Measurements were carried out in tripli-
cate experiments.
2.3. Immunoblot analysis
LI90 cells were stimulated with TGF-b1 R&D
.Systems, Mineapolis, MN, USA; 5 ngrml , tumor
necrosis factor-a TNF-a , 250 Urml; Amgen Bio-
.logicals, Thousand Oaks, CA, USA and interleukin-
 .1a IL-1a , 10 ngrml; R&D for 48 h. Immunoblot
analysis for calponin and a-SMA was carried out
w xtwice as previously described 13,22 . Anti-a-SMA
monoclonal antibodies, clone 1A4, which are mono-
specific to a-SMA, were purchased from Sigma St.
.Louis, MO, USA . The previous study suggested that
the polyclonal antibody raised against the h1 isoform
of aortic calponin cross-reacted with acidic- and h2-
w xcalponin 13 . Cells were homogenized with buffer
containing 1% DTT, 1 mM EGTA, 1 mM EDTA, 0.1
M KCl, 5 mgrml leupeptin, and 20 mgrml trypsin
inhibitor in 20 mM Tris–HCl, pH 7.5. Each ho-
mogenate was treated with 2% sodium dodecyl sul-
 .fate SDS under reducing conditions and heated for
3 min in a boiling water bath. After centrifugation,
proteins in homogenates from equivalent numbers of
cells were electrophoresed on 9% SDS-polyacryl-
amide gels. Separated proteins were transferred to
nitrocellulose filters which were incubated with each
antibody. A second incubation was done with a rabbit
anti-mouse IgG conjugated with HRP Dakopatts,
.Glostrup, Denmark .
2.4. RNA extraction and amplification using re˝erse
( )transcription-polymerase chain reaction RT-PCR
LI90 cells were cultured to confluence, washed
twice, and incubated in fresh medium with or without
 .the addition of TGF-b1 10 ngrml for 24 h. Total
RNA from the harvest cells was isolated by the acid
guanidium-thiocyanate–phenol–chloroform method
w x23 , and 2 mg of total RNA was converted to cDNA
 .by reverse transcriptase Superscript, Gibco . The
amplification procedure consisted of 30 cycles 948C,
.40 s; 608C, 30 s; 728C, 1.5 min with the following
w xoligonucleotide primer sets 13 . The calponin-h1 for-
ward primer sequence was 5X-GAG TGT GCA GAC
GGA ACT TCA GCC-3X; the reverse was 5X-GTC
X TGT GCC CAA CTT GGG GTC-3 the pair gener-
.ated a 671 bp fragment . The calponin-h2 forward
primer was 5X-CTG CAG AGC GGG GTG GAC
ATT GGC-3X; the reverse was 5X-GCC GGC CTC
X CTC CTG GTA GTA AGG-3 the pair generated a
.519 bp fragment . The glyceraldehyde-3-phosphate
 . Xdehydrogenase G3PDH forward primer was 5 -CCC
ATC ACC ATC TTC CAG GA-3X; the reverse was
X X 5 -TTG TCA TAC CAG GAA ATG AGC-3 the
.pair generated a 731 bp fragment . Each final PCR
products was electrophoresed on 1% agarose gels.
3. Results
3.1. Effect of TGF-b1 on production of HA, laminin,
and HGF by LI90 cells
Since it is known that TGF-b is a key mediator of
hepatic fibrosis in acute as well as chronic liver
damage, we investigated the effect of TGF-b treat-
ment on the productions of HA, laminin, and HGF in
cultures of LI90 cells. For this purpose, LI90 cells
were exposed to TGF-b 1 for 48 h at nearly confluent
culture. In the absence of TGF-b1 in LI90 cell
cultures, significant amounts of HA, laminin, and
 .HGF were actively secreted in the medium Fig. 1 .
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Fig. 1. Production of hyaluronic acid, laminin, and HGF in the presence of various concentrations of TGF-b1 in LI90 cells. LI90 cells
were incubated in the presence of TGF-b1 at the indicated concentrations for 48 h. Results are normalized for cell numbers. The results
shown are means for three experiments, and error bars represent "SE.
The addition of TGF-b1 to LI90 cultures resulted in
dose-dependent increases of HA and laminin, whereas
the HGF production was significantly reduced Fig.
. w x1 . Ramadori et al. 24 observed no effect of TGF-b1
treatment on freshly isolated Ito cells. The lack of
effect of TGF-b on freshly isolated cells is explained
by the lack of receptor expression in quiescent Ito
cells. However, LI90 cells of the present study ex-
pressed all components of the TGF-b receptor com-
 .plex data not shown . Therefore, these LI90 cells are
compatible with activated Ito cells from the human
liver and may be useful for in vitro experiments on
the interaction between TGF-b1 and human Ito cells
for the understanding of the progression of activated
cells in the fibrogenic process.
3.2. Effect of TGF-b1 on proliferation of LI90 cells
The proliferative response of mesenchymal cells to
TGF-b has been suggested to be mediated via an
autocrine secretion of platelet-derived growth factor
 . w xPDGF 25 . However, we found that LI90 cells
were only partially inhibited by TGF-b1 in the pres-
 .ence of FCS, in a dose-dependent manner Fig. 2 . At
the highest concentration of TGF-b1 tested 10
.ngrml , LI90 cells were inhibited by 39% over the
4-day period. TNF-a and IL-1a each at maximally
.effective concentrations had no significant effect on
 .the growth of LI90 cells Data not shown . Casini et
w xal. 16 have also reported that TGF-b1 reduced
DNA synthesis in cultured human Ito cells. The
mechanisms underlying the growth-inhibiting effects
of TGF-b1 on LI90 cells and the interactions of
Fig. 2. Effect of TGF-b1 on the growth of LI90 cells. LI90 cells
were cultured with various concentrations of TGF-b1. After 96
h, the cell numbers were counted. The results shown are means
for three experiments, and error bars represent "SE.
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TGF-b1 with other growth-promoting or growth-in-
hibitory substances are unclear.
3.3. Effect of TGF-b1 on a-SMA and calponin-h1
expressions in LI90 cells
We next examined the effect of TGF-b1 on the
protein levels of a-SMA and calponin-h1, which is
w xonly detectable in smooth muscle tissues 11,14 . As
shown in Fig. 3, the expression of a-SMA on LI90
cells cultured in the absence of TGF-b1 suggests that
these cells exhibit the characteristics of activated Ito
cells; however, low levels of calponin were detected
on LI90 cells. When LI90 cells were cultured in the
presence of TGF-b1, the a-SMA expression was
 .slightly increased after 48 h of treatment Fig. 3 . The
treatment with exogenous TGF-b1 was also able to
increase the expression of calponin, another smooth
muscle-specific protein that may regulate contractility
 .Fig. 3 . When we tested two proinflammatory cy-
tokines for their capacity to coordinate the regulation
of the expression of a-SMA and calponin in LI90
cells, we observed that both TNF-a and IL-1a did
not possess the ability to stimulate the expression of
 .these proteins Fig. 3 . The molecular mass of acidic
calponin is slightly higher than that of calponin-h1
and -h2. Thus, immunoreactive proteins detected by a
polyclonal antibody raised against the calponin-h1
are thought to correspond to calponin-h1 or -h2.
To determine which isoform of calponin is af-
fected by the addition of TGF-b1 to LI90 cells, we
analyzed the levels of specific mRNA transcripts of
calponin-h1 and -h2 by RT-PCR. The treatment of
TGF-b1 to LI90 cells resulted in a significant in-
Fig. 3. Immunoblot analysis of a-SMA and calponin in LI90 cells treated with TGF-b1. Proteins from equal numbers of cells were
resolved on 9% SDS polyacrylamide gels and transferred to nitrocellulose. a-SMA and calponin were detected with the use of a
monoclonal antibody for a-SMA or a polyclonal antibody for calponin-h1. Results are representative of two individual experiments.
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Fig. 4. RT-PCR analysis of mRNAs of calponin-h1, -h2, and G3PDH in LI90 cells treated with TGF-b1. PCR-amplified products from
cDNAs generated in reverse transcriptase reaction from 2 mg of total RNA from LI90 cells using sense and anti-sense primers specific for
calponin-h1, -h2, and G3PDH. The predicted size of calponin-h1 product is 671 bp, calponin-h2 product of 519 bp, and G3PDH product
of 731 bp. Higher calponin-h1 mRNA levels were observed in LI90 cells cultured in the presence of TGF-b1 than in the absence. Results
are representative of two individual experiments.
crease of calponin-h1 mRNA levels after 24 h of
 .incubation Fig. 4 . The mRNA levels of calponin-h2
and G3PDH were identical in both the absence and
presence of TGF-b1, demonstrating that the differ-
ence in the expression of calponin-h1 mRNA were
not due to variability in gel loading or degradation of
RNA during extraction. This result suggests that the
induction of calponin-h1 by TGF-b1 is regulated at
the level of mRNA in activated Ito cells. Recent
studies demonstrated that the calponin-h1 gene is
expressed in a developmentally regulated and specific
w xpattern in smooth muscle cells 11 . Consequently,
the induction of both calponin-h1 and a-SMA in
LI90 cells by TGF-b1 suggested that this ligand
maintains a smooth muscle cell phenotype in
human-activated Ito cells in the process of hepatic
fibrosis.
4. Discussion
It is well known that TGF-b1 is a potent regulator
of ECM synthesis and deposition in various cell types
w x15 . TGF-b1 stimulates the synthesis of collagen
and proteoglycans by cultured Ito cells that, in turn,
can express the TGF-b1 gene. Along this line, the
presence of autocrine or paracrine loops for TGF-b1
that might contribute to the propagation and self
perpetuation of the fibrogenic process has been hy-
w xpothesized 26 . However, most in vitro studies of Ito
( )N. Ueki et al.rBiochimica et Biophysica Acta 1403 1998 28–3634
cells have been performed with rat liver-derived cell
populations. Our present experiments were carried
out with the human Ito cell line, LI90, which was
recently established from a hepatic mesenchymal tu-
w xmor 18 . LI90 cells exhibited unique characteristics
in that they secreted both ECM and HGF, and ex-
pressed a-SMA without the addition of TGF-b1.
Using cultured LI90 cells, we also confirmed the
findings published by others that TGF-b1 increases
both ECM synthesis and a-SMA expression. ECM
components are known to act as a scaffold for proteo-
glycans and glycoproteins and thus form a depository
for TGF-b, PDGF, HGF, and the fibroblast growth
factors. These matrix-bound mediators could provide
an ongoing signal for proliferation, matrix produc-
tion, and augmented growth factor expression. In this
way, the de novo synthesis of collagens could create
an intralesional locus of profibrotic growth factors
which sustains the proliferative response. Conse-
quently, our present results indicate that LI90 cells
are compatible with activated Ito cells, and our in
vitro data concerning the TGF-b1 effects on LI90
cells are relevant for the understanding of the perpet-
uation of activated Ito cells and the fibrogenic pro-
cess in the human liver.
The repair of a liver injury often involves the
activity of specialized mesenchymal cells referred to
w xas myofibroblasts 27 . These cells display a marked
increase of collagen biosynthesis as well as a modi-
fied actin cytoskeleton that has been proposed to
w xcontribute to wound contracture 28 . In general,
these cells express an intermediate phenotype be-
tween that of fibroblasts and smooth muscle cells.
Our studies and those of others have demonstrated
that the morphologically identified myofibroblast is
composed of several subclasses that can be distin-
guished on the basis of their caldesmon and actin
w xisoform content 22,29 . Ultrastructural and immuno-
cytochemical studies of fibrosing liver injury have
shown that Ito cells may undergo a gradual transition
from a ‘vitamin A-storage’ phenotype to a
‘myofibroblast-like’ phenotype, as called activated
w xIto cells 1 . This process is associated with a marked
increase of ECM synthesis and the expression of
a-SMA, a well-characterized smooth muscle marker
w x30 . However, very little is known about factors
which regulate the expression of other smooth mus-
cle-specific proteins in activated Ito cells. Although
a-SMA is the most abundant protein in smooth mus-
cle cells and is required for the principle function of
smooth muscle contraction, its expression alone does
not provide definitive evidence for smooth muscle
w xcell lineage 17 . Of particular interest is a recent
w xstudy by Shah et al. 31 which demonstrated that
TGF-b stimulated the differentiation of neural crest
cells into smooth muscle cells, based on morphologi-
cal criteria and the inductions of a-SMA and
w xcalponin-h1. Hautmann et al. 32 also demonstrated
that TGF-b1 increased the expression of two other
smooth muscle differentiation marker genes, smooth
muscle myosin heavy chain and calponin-h1, in addi-
tion to a-SMA. Consistent with this finding, we
demonstrated that TGF-b coordinate regulation at the
protein level of both a-SMA and calponin-h1 in LI90
cells. Consequently, TGF-b 1 may function as a posi-
tive differentiation factor for myofibroblasts, and be
involved in maintenance of a more differentiated
state in activated Ito cells during fibrocontractive
liver diseases.
When we tested two proinflammatory cytokines
for their capacity to coordinate the regulation of the
expression of a-SMA and calponin-h1 in LI90 cells,
we observed that IL-1 and TNF-a did not possess the
ability to stimulate the expression of these proteins.
However, these cytokines stimulated, at least in part,
the production of ECM components in LI90 cells
 .data not shown . We know that many growth factors
and cytokines are capable of stimulating fibroblast
replication, ECM synthesis, and fibrosis formation in
vivo. However, with the exception of TGF-b, others
factors do not directly affect the expression of smooth
muscle differentiation marker proteins including a-
SMA and calponin-h1 in fibroblasts, and hence they
presumably are not responsible for the differentiation
of typical myofibroblasts. It has been suggested that
myofibroblasts of wounds arise locally from more
specialized cells such as perisinusoidal Ito cells in the
liver, mesangial cells in the glomerulus, interstitial
cells in the lung septa, and perivascular smooth mus-
cle cells. The phenotypic modulation of myofibrob-
lasts, whatever the origin, is an important step in
wound healing and in pathological phenomena char-
acterized by tissue retraction and fibrosis. Our results
confirm and extend the notion of the role of TGF-b1
in both differentiation and fibrosis. All these proper-
ties of TGF-b1 support the assumption that this
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factor plays a crucial role in the evolution of hepatic
fibrosis and particularly in myofibroblast formation,
such as the perpetuation in activated Ito cells, possi-
bly after that other growth factors have stimulated
fibroblasts proliferation. The regulated expression of
ca lpon in -h1 in sm ooth m uscle during
differentiatonrdevelopment and phenotypic modula-
w xtion has been observed 33,34 , suggesting its impor-
tance in the functional maturation of smooth muscle
myofilaments and its validity as a marker of differen-
tiated smooth muscle cells. The identification of
smooth muscle features promoted by TGF-b1 corre-
lates with the hypothesis that the perpetuation of
activated Ito cells coincides with their contractile
behavior, implying that these cells may function as
regulators of intrahepatic blood flow in liver injury
w x35 .
In conclusion, we have shown in this report the
stimulatory effect of TGF-b1 on the expressions of
calponin-h1 and a-SMA in addition to ECM produc-
tion in cultures of LI90 cells exhibiting the character-
istics of human-activated Ito cells. These results
demonstrate the importance of the perpetuation of
‘activated’ Ito cells in the induction of both the
contractile and migratory responses of these cells
promoted by TGF-b1. In the central part of hepatic
fibrosis, activated Ito cells deposit excessive amounts
of ECM, a phenomenon known as desmoplasia that
may represent an exaggerated response of tissue re-
traction and remodeling. TGF-b1 should be consid-
ered key in situations related to both the fibrotic
response and tissue contraction. In this setting, acti-
vated Ito cells may induce the contraction of fibrotic
bands, leading to a physical distortion of the lobular
architecture and a secondary disruption of normal
hepatic blood flow.
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